Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of enteric diseases
3.2.1.2 Technological advancements in diagnostic technologies
3.2.1.3 Growing demand for preventive healthcare services
3.2.1.4 Rising healthcare expenditure and investments
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with enteric disease testing
3.2.2.2 Complexity of testing procedures
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
3.8 Future market trends
3.9 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Disease, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Bacterial enteric disease
5.2.1 C. difficile
5.2.2 E. coli
5.2.3 Salmonella
5.2.4 Campylobacter
5.2.5 Listeria
5.2.6 Shigellosis
5.3 Viral enteric disease
5.3.1 Rotavirus infection
5.3.2 Norovirus infection
5.4 Parasitic enteric disease
5.4.1 Giardiasis
5.4.2 Amebiasis
5.4.3 Cryptosporidiosis
Chapter 6 Market Estimates and Forecast, By Test Type, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Immunoassay
6.3 Molecular
6.4 Conventional
6.5 Chromatography & spectrometry
6.6 Other test types
Chapter 7 Market Estimates and Forecast, By End-use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Diagnostic laboratories
7.4 Research & academic institutes
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Becton, Dickinson and Company
9.3 Biomerica, Inc.
9.4 BIOMÉRIEUX S.A
9.5 Bio-Rad Laboratories, Inc.
9.6 Cepheid
9.7 Coris BioConcept
9.8 DiaSorin S.p.A.
9.9 Eurofins Scientific SE
9.10 Merck KGaA
9.11 Meridian Bioscience
9.12 Quest Diagnostics Incorporated
